Home » Allergan Closes Purchase of Aczone Gel for $150 Million
Allergan Closes Purchase of Aczone Gel for $150 Million
Allergan’s wholly owned subsidiary, Allergan Sales, LLC, announced the completion of acquisition of Aczone Gel 5% product of QLT USA, Inc., a wholly owned subsidiary of QLT Inc. Aczone Gel 5% product is a topical treatment for acne vulgaris.
RTTNews
RTTNews
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May